World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
31738
World Ranking
11289
National Ranking
5793

Overview

Elliot M. Frohman is affiliated with The University of Texas at Austin in the United States. Their research primarily focuses on Medicine, with emphasis on Neurology, Pathology and Forensic Medicine, and Ophthalmology. Other subfields of study include Infectious Diseases and Rheumatology.

The scientist's work encompasses several main topics, such as:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Retinal and Optic Conditions
  • Long-Term Effects of COVID-19
  • Ocular Diseases and Behçet's Syndrome
  • Systemic Lupus Erythematosus Research
  • Optical Coherence Tomography Applications

Notable recent papers authored or coauthored by Elliot M. Frohman include:

  • Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack, 2020, Journal of the Neurological Sciences
  • Diagnosis and classification of optic neuritis, 2022, The Lancet Neurology
  • APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies, 2021, Neurology
  • The Role of Optical Coherence Tomography Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis Diagnosis, 2022, Neurology
  • Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis, 2023, Journal of Neuroinflammation

Their frequent coauthors include:

  • Teresa C. Frohman
  • Scott S. Zamvil
  • Laura J. Balcer
  • Roberto Alejandro Cruz
  • Thomas Varkey

Key publication venues for this researcher are:

  • Neurology Neuroimmunology & Neuroinflammation
  • Neurology
  • Journal of the Neurological Sciences
  • Frontiers in Neurology
  • The Lancet Neurology

Best Publications

  • Multiple Sclerosis — The Plaque and Its Pathogenesis

    Elliot M. Frohman;Michael K. Racke;Cedric S. Raine

  • Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines.

    D. S. Goodin;Elliot Frohman;G. P. Garmany;J. Halper

  • Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis

    Jennifer B. Fisher;Dina A. Jacobs;Clyde E. Markowitz;Steven L. Galetta

  • Quantitative sensory testing: Report of the therapeutics and technology assessment subcommittee of the American academy of neurology

    M. E. Shy;E. M. Frohman;Y. T. So;J. C. Arezzo

  • Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial

    Jerry S. Wolinsky;Ponnada A. Narayana;Paul O'Connor;Patricia K. Coyle

  • Immune surveillance in multiple sclerosis patients treated with natalizumab

    Olaf Stüve;Olaf Stüve;Christina M Marra;Keith R Jerome;Keith R Jerome;Keith R Jerome;Linda Cook;Linda Cook;Linda Cook

  • RETINAL NERVE FIBER LAYER IS ASSOCIATED WITH BRAIN ATROPHY IN MULTIPLE SCLEROSIS

    E. Gordon-Lipkin;B. Chodkowski;D. S. Reich;S. A. Smith

  • The neuro-ophthalmology of multiple sclerosis

    E.M. Frohman;T.C. Frohman;D.S. Zee;R. McColl

  • Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.

    Lauren S. Talman;Esther R. Bisker;David J. Sackel;David A. Long

  • Optical coherence tomography: a window into the mechanisms of multiple sclerosis.

    Elliot M Frohman;James G Fujimoto;Teresa C Frohman;Peter A Calabresi

  • Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography

    Shiv Saidha;Stephanie B. Syc;Mohamed A. Ibrahim;Christopher Eckstein

  • Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis

    Stephanie B. Syc;Shiv Saidha;Scott D. Newsome;John N. Ratchford

  • Assessment: Prevention of post-lumbar puncture headaches: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

    Randolph W. Evans;Randolph W. Evans;Carmel Armon;Elliot M. Frohman;Douglas S. Goodin

  • The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosis

    V. Devonshire;Y. Lapierre;R. Macdonell;C. Ramo-Tello

  • Optical Coherence Tomography Reflects Brain Atrophy in Multiple Sclerosis: A Four-Year Study

    Shiv Saidha;Omar Al-Louzi;John N. Ratchford;Pavan Bhargava

  • Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies

    J. N. Ratchford;M. E. Quigg;A. Conger;Teresa Frohman

  • The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects

    Alireza Minagar;Michael H. Barnett;Michael H. Barnett;Ralph H.B. Benedict;Daniel Pelletier

  • MULTIPLE SCLEROSIS AND THE UROLOGIST

    Scott E. Litwiller;Elliot M. Frohman;Philippe E. Zimmern

  • Optical coherence tomography and disease subtype in multiple sclerosis

    M. Pulicken;E. Gordon-Lipkin;L. J. Balcer;Elliot Frohman

  • Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.

    Shiv Saidha;Stephanie B. Syc;Mary K. Durbin;Christopher Eckstein

Frequent Co-Authors

Laura J. Balcer
Laura J. Balcer New York University
Peter A. Calabresi
Peter A. Calabresi Johns Hopkins University School of Medicine
Michael K. Racke
Michael K. Racke Quest Diagnostics (United States)
Olaf Stüve
Olaf Stüve The University of Texas Southwestern Medical Center
Steven Galetta
Steven Galetta New York University Langone Medical Center
Robert Zivadinov
Robert Zivadinov University at Buffalo, State University of New York
Scott S. Zamvil
Scott S. Zamvil University of California, San Francisco
Gary Cutter
Gary Cutter University of Alabama at Birmingham
Bernhard Hemmer
Bernhard Hemmer Technical University of Munich
David S. Zee
David S. Zee Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring healthcare professionals have a diverse range of online degree options that can open doors to specialized career paths. For those interested in healthcare leadership, evaluating mha degree cost is important when choosing a program that balances affordability and quality for future administrators.

Nurses looking to take the next step in their careers may consider the cheapest online dnp programs, which allow for advanced clinical or academic roles without the need for full-time, on-campus attendance.

For those drawn to pharmacology, earning a pharmacy school online can be a flexible option for gaining essential qualifications, while also addressing cost through affordable programs.

Additionally, the rising demand for digital health records makes a him bachelor's degree online attractive for those seeking roles in health information management.

Exploring these online degree options is a strategic way for students to align their education with evolving career opportunities in medicine and healthcare.

Best Scientists Citing Elliot M. Frohman

Trending Scientists

Recently Published Articles